Compare Bio Protocol (BIO) vs Measurable Data Token (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Measurable Data Token — how do they compare? Bio Protocol trades at Rp436.37 (market cap Rp999,49M, Rp162,68M 24h volume), while Measurable Data Token trades at Rp69.73 (market cap Rp72,67M, Rp18,99M 24h volume). The key difference: Bio Protocol is far larger — about 13.8× Measurable Data Token's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Measurable Data Token's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Measurable Data Token for 19 Days on average.
| BIO | MDT | |
|---|---|---|
Market Cap | Rp999,49M | Rp72,67M |
Volume (24h) | Rp162,68M | Rp18,99M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 676,2M MDT |
Typical Hold Time | 18 Days | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Measurable Data Token (MDT) is a cryptocurrency with a market cap of Rp72.67 million and a circulating supply of 676.2 million tokens. The average hold time is 19 days, indicating moderate trader retention. Current price data is unavailable, but the asset operates in the data economy sector, focusing on decentralized data exchange. Recent news shows no major protocol updates, with attention diverted to a similarly tickered stock, suggesting low crypto-specific developments. Trading volumes and network activity metrics are not provided, limiting technical assessment. The token's niche utility in data monetization remains its core value proposition amid quiet ecosystem growth.
Outlook: MDT presents speculative potential due to its data utility focus, but risks include low liquidity, minimal developer activity, and market obscurity. Key opportunities lie in adoption growth within decentralized data markets, while major risks involve high volatility and regulatory uncertainty for data tokens. Investors should monitor on-chain metrics and exchange listings for momentum shifts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Measurable Data Token
Measurable Data Token (MDT) is a decentralized data exchange ecosystem connecting users, data providers, and data buyers and denominates the value of data.
Read more on MDT →
